Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ~60,000 human exomes
- 26 October 2015
- journal article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 116 (4), 298-304
- https://doi.org/10.1016/j.ymgme.2015.10.010
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01NS083726)
This publication has 14 references indexed in Scilit:
- Why screen newborns for profound and partial biotinidase deficiency?Molecular Genetics and Metabolism, 2015
- A general framework for estimating the relative pathogenicity of human genetic variantsNature Genetics, 2014
- A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosisJournal of Inherited Metabolic Disease, 2014
- Mutations in FBXL4 Cause Mitochondrial Encephalopathy and a Disorder of Mitochondrial DNA MaintenanceAmerican Journal of Human Genetics, 2013
- Neurological Outcome in Cerebrotendinous Xanthomatosis Treated With Chenodeoxycholic AcidClinical Neuropharmacology, 2013
- Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++PLoS Computational Biology, 2010
- Clinical imaging and neuropathological correlations in an unusual case of cerebrotendinous xanthomatosisClinical Neuropathology, 2010
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- Cerebrotendinous XanthomatosisArchives of Neurology, 2005
- Clinical and molecular genetic characteristics of patients with cerebrotendinous xanthomatosisBrain, 2000